Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2006

View Archived Issues

BTG closes busy year

AZD-2171, combined with chemotherapy or EGFR inhibitor, is active in patients with solid tumors

Focus on BAY-579352 at ASCO

ISTA licenses new investigational glaucoma products from Senju

NeoRx changes name to Poniard Pharmaceuticals

Epeius awarded grant to support cancer gene therapy trials with Rexin-G

MQX-503 studied in European trial for Raynaud's phenomenon

Exenatide snapshots from the American Diabetes Association annual meeting

Synergistic weight loss seen with bupropion/naltrexone combination

Galiximab/rituximab combination feasible and active in non-Hodgkin's lymphoma

GDNF gene therapy is neuroprotective in Huntington's disease / News in Context

Discovery and potential preclinical antiobesity efficacy of PSN-632408, a GPR119 agonist

NicOx granted generic name naproxcinod for HCT-3012

Phase Ia study of Reolysin with radiation completes enrollment

ARQ-501 enters phase II development

New phase II study investigates PXD-101 for mesothelioma

Aeolus selects AEOL-11207 as first development candidate

New preclinical findings for CF-101

U.K. acute pain study of cannabinor cleared to begin

Praecis ceases efforts to license or sell Plenaxis

Three-hour imaging time point most appropriate for ThromboView

Immunological bioactivity and antiviral properties of VGV-1 confirmed

Lenalidomide study snapshots from the European Hematology Association congress

Study evaluates AVE-7688 pharmacodynamics

Cardioprotective activity of first generation inhibitor of malonyl-CoA decarboxylase

Orphan drug designation for Anthim

Remicade sBLA in psoriatic arthritis accepted for filing

Recent patents describe new therapeutic strategies for endocrine-related disorders

Novel antibacterial agents disclosed in two recent Pfizer patents

New fixed-dose formulations for BPH described in recent GSK patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...